Literature DB >> 15075212

Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2.

Huiping Zhou1, Karnam S Murthy.   

Abstract

We examined expression of sphingosine 1-phosphate (S1P) receptors and sphingosine kinase (SPK) in gastric smooth muscle cells and characterized signaling pathways mediating S1P-induced 20-kDa myosin light chain (MLC(20)) phosphorylation and contraction. RT-PCR demonstrated expression of SPK1 and SPK2 and S1P(1) and S1P(2) receptors. S1P activated G(q), G(13), and all G(i) isoforms and stimulated PLC-beta1, PLC-beta3, and Rho kinase activities. PLC-beta activity was partially inhibited by pertussis toxin (PTX), Gbeta or Galpha(q) antibody, PLC-beta1 or PLC-beta3 antibody, and by expression of Galpha(q) or Galpha(i) minigene, and was abolished by a combination of antibodies or minigenes. S1P-stimulated Rho kinase activity was partially inhibited by expression of Galpha(13) or Galpha(q) minigene and abolished by expression of both. S1P stimulated Ca(2+) release that was inhibited by U-73122 and heparin and induced concentration-dependent contraction of smooth muscle cells (EC(50) 1 nM). Initial contraction and MLC(20) phosphorylation were abolished by U-73122 and MLC kinase (MLCK) inhibitor ML-9. Initial contraction was also partially inhibited by PTX and Galpha(q) or Gbeta antibody and abolished by a combination of both antibodies. In contrast, sustained contraction and MLC(20) phosphorylation were partially inhibited by a PKC or Rho kinase inhibitor (bisindolylmaleimide and Y-27632) and abolished by a combination of both inhibitors but not affected by U-73122 or ML-9. These results indicate that S1P induces 1) initial contraction mediated by S1P(2) and S1P(1) involving concurrent activation of PLC-beta1 and PLC-beta3 via Galpha(q) and Gbetagamma(i), respectively, resulting in inositol 1,4,5-trisphosphate-dependent Ca(2+) release and MLCK-mediated MLC(20) phosphorylation, and 2) sustained contraction exclusively mediated by S1P(2) involving activation of RhoA via Galpha(q) and Galpha(13), resulting in Rho kinase- and PKC-dependent MLC(20) phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075212     DOI: 10.1152/ajpcell.00429.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  32 in total

1.  An expression screen reveals modulators of class II histone deacetylase phosphorylation.

Authors:  Shurong Chang; Svetlana Bezprozvannaya; Shijie Li; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-27       Impact factor: 11.205

2.  S1P₂ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology.

Authors:  Grant M Sumida; W Daniel Stamer
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

Review 3.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

Review 4.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

5.  Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors.

Authors:  Puneet S Jolly; Meryem Bektas; Kenneth R Watterson; Heidi Sankala; Shawn G Payne; Sheldon Milstien; Sarah Spiegel
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

6.  Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.

Authors:  Ancy D Nalli; Divya P Kumar; Othman Al-Shboul; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

7.  Sphingosine-1-phosphate elicits receptor-dependent calcium signaling in retinal amacrine cells.

Authors:  Scott Crousillac; Jeremy Colonna; Emily McMains; Jill Sayes Dewey; Evanna Gleason
Journal:  J Neurophysiol       Date:  2009-09-23       Impact factor: 2.714

Review 8.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

9.  Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1.

Authors:  K S Murthy
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

10.  Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor.

Authors:  Sho Ishizawa; Junko Takahashi-Fujigasaki; Yasushi Kanazawa; Keiichiro Matoba; Daiji Kawanami; Tamotsu Yokota; Takeo Iwamoto; Naoko Tajima; Yoshinobu Manome; Kazunori Utsunomiya
Journal:  Clin Exp Nephrol       Date:  2014-01-25       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.